Physiological modeling of isoprene dynamics in exhaled breath

Journal of Theoretical Biology

Volumn 267, Issue 4, 2010, Pages 626-637

  King, Julian ^a,b,f   Koc, Helin ^b,d   Unterkofler, Karl ^a,b   Mochalski, Pawel ^a,c   Kupferthaler, Alexander ^a   Teschl, Gerald ^d   Teschl, Susanne ^e   Hinterhuber, Hartmann ^f   Amann, Anton ^a,f  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b VORARLBERG UNIVERSITY OF APPLIED SCIENCES   (Austria)

^c INSTITUTE OF NUCLEAR PHYSICS   (Poland)

^d UNIVERSITY OF VIENNA   (Austria)

^e UNIVERSITY OF APPLIED SCIENCES TECHNIKUM WIEN   (Austria)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Breath gas analysis; Hemodynamics; Isoprene; Modeling; Volatile organic compounds

Indexed keywords

ISOPRENE; VOLATILE ORGANIC COMPOUND;

BIOTRANSFORMATION; BLOOD; ISOPRENE; PHYSIOLOGY; REFLECTIVITY; TRACE GAS; VENTILATION; VOLATILE ORGANIC COMPOUND;

ARTICLE; BLOOD SAMPLING; BREATH ANALYSIS; BREATHING; CONTROLLED STUDY; END TIDAL CARBON DIOXIDE TENSION; ERGOMETER; GAS ANALYSIS; HEART OUTPUT; HUMAN; HUMAN EXPERIMENT; LUNG HEMODYNAMICS; LUNG VENTILATION; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STEADY STATE;

ADULT; BREATH TESTS; BUTADIENES; COMPUTER SIMULATION; ERGOMETRY; EXERCISE; EXHALATION; HEMITERPENES; HUMANS; MALE; MODELS, BIOLOGICAL; PENTANES; PULMONARY GAS EXCHANGE; REPRODUCIBILITY OF RESULTS;

EID: 77957321090     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2010.09.028     Document Type: Article

References (97)

1. Amann A., Poupart G., Telser S., Ledochowski M., Schmid A., Mechtcheriakov S. Applications of breath gas analysis in medicine. Int. J. Mass Spectrom. 2004, 239:227-233.
2. Amann, A., Smith, D. (Eds.), 2005. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring. World Scientific, Singapore.
3. Amann A., Spanel P., Smith D. Breath analysis: the approach towards clinical applications. Mini Rev. Med. Chem. 2007, 7:115-129.
4. Amann A., Telser S., Hofer L., Schmid A., Hinterhuber H. Breath gas as a biochemical probe in sleeping individuals. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring 2005, 305-316. World Scientific, Singapore. A. Amann, D. Smith (Eds.).
5. Anderson J.C., Babb A.L., Hlastala M.P. Modeling soluble gas exchange in the airways and alveoli. Ann. Biomed. Eng. 2003, 31:1402-1422.
6. Anderson J.C., Hlastala M.P. Breath tests and airway gas exchange. Pulm. Pharmacol. Ther. 2007, 20:112-117.
7. Banks H.T., Fitzpatrick B.G. Statistical methods for model comparison in parameter estimation problems for distributed systems. J. Math. Biol. 1990, 28:501-527.
8. Banks, H.T., Holm, K., Robbins, D., in press. Standard error computations for uncertainty quantification in inverse problems: asymptotic theory vs. bootstrapping. Math. Comput. Modelling 52, 1610-1625.
9. Banks H.T., Tran H.T. Mathematical and Experimental Modeling of Physical and Biological Processes 2009, CRC Press, Boca Raton.
10. Batzel J.J., Kappel F., Schneditz D., Tran H.T. Cardiovascular and Respiratory Systems: Modeling, Analysis, and Control 2007, SIAM, Philadelphia.
11. Bock H.G. Numerical treatment of inverse problems in chemical reaction kinetics. Modelling of Chemical Reaction Systems 1981, 102-125. Springer, Heidelberg. K. Ebert, P. Deuflhard, W. Jäger (Eds.).
12. Bock, H.G., 1987. Randwertproblemmethoden zur Parameteridentifizierung in Systemen nichtlinearer Differentialgleichungen. Ph.D. Thesis, Universität Bonn.
13. Bogaards J.J., Freidig A.P., van Bladeren P.J. Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling. Chem. Biol. Interact. 2001, 138:247-265.
14. Box G., Jenkins G.M., Reinsel G. Time Series Analysis: Forecasting & Control 1994, Prentice-Hall, Englewood Cliffs. third ed.
15. Brown M.S., Goldstein J.L. Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. J. Lipid Res. 1980, 21:505-517.
16. Brun R., Kühni M., Siegrist H., Gujer W., Reichert P. Practical identifiability of ASM2d parameters-systematic selection and tuning of parameter subsets. Water Res. 2002, 36:4113-4127.
17. Buszewski B., Kesy M., Ligor T., Amann A. Human exhaled air analytics: biomarkers of diseases. Biomed. Chromatogr. 2007, 21:553-566.
18. Cailleux A., Allain P. Isoprene and sleep. Life Sci. 1989, 44:1877-1880.
19. Cailleux A., Cogny M., Allain P. Blood isoprene concentrations in humans and in some animal species. Biochem. Med. Metab. Biol. 1992, 47:157-160.
20. Cailleux A., Moreau X., Delhumeau A., Allain P. Decrease of isoprene concentrations in blood during general anesthesia. Biochem. Med. Metab. Biol. 1993, 49:321-325.
21. Capodicasa E., Brunori F., Medio G.E.D., Pelli M.A., Vecchi L., Buoncristiani U. Effect of two-hour daily hemodialysis and sham dialysis on breath isoprene exhalation. Int. J. Artif. Organs 2007, 30:583-588.
22. Capodicasa E., Trovarelli G., Medio G.E.D., Pelli M.A., Lippi G., Verdura C., Timio M. Volatile alkanes and increased concentrations of isoprene in exhaled air during hemodialysis. Nephron 1999, 82:331-337.
23. Cintrón-Arias A., Banks H.T., Capaldi A., Lloyd A.L. A sensitivity matrix based methodology for inverse problem formulation. J. Inv. Ill-Posed Probl. 2009, 17:545-564.
24. Cobelli C., DiStefano J.J. Parameter and structural identifiability concepts and ambiguities: a critical review and analysis. Am. J. Physiol. 1980, 239:R7-R24.
25. Cope K.A., Watson M.T., Foster W.M., Sehnert S.S., Risby T.H. Effects of ventilation on the collection of exhaled breath in humans. J. Appl. Physiol. 2004, 96:1371-1379.
26. Csanády G.A., Filser J.G. Toxicokinetics of inhaled and endogenous isoprene in mice, rats, and humans. Chem. Biol. Interact. 2001, 135-136:679-685.
27. Davidian M., Giltinan D.M. Nonlinear Models for Repeated Measurement Data 1995, Chapman and Hall, New York.
28. Deneris E.S., Stein R.A., Mead J.F. In vitro biosynthesis of isoprene from mevalonate utilizing a rat liver cytosolic fraction. Biochem. Biophys. Res. Commun. 1984, 123:691-696.
29. Dogan G. Bootstrapping for confidence interval estimation and hypothesis testing for parameters of system dynamics models. Syst. Dyn. Rev. 2007, 23:415-436.
30. Farhi L.E. Elimination of inert gas by the lung. Respir. Physiol. 1967, 3:1-11.
31. Filser J.G., Csanády G.A., Denk B., Hartmann M., Kauffmann A., Kessler W., Kreuzer P.E., Pütz C., Shen J.H., Stei P. Toxicokinetics of isoprene in rodents and humans. Toxicology 1996, 113:278-287.
32. Fiserova-Bergerova, V. (Ed.), 1983. Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination. CRC Press, Boca Raton.
33. Fritz G. Targeting the mevalonate pathway for improved anticancer therapy. Curr. Cancer Drug Targets 2009, 9:626-638.
34. Gelmont D., Stein R.A., Mead J.F. Isoprene-the main hydrocarbon in human breath. Biochem. Biophys. Res. Commun. 1981, 99:1456-1460.
35. Gerlowski L.E., Jain R.K. Physiologically based pharmacokinetic modeling: principles and applications. J. Pharm. Sci. 1983, 72:1103-1127.
36. Golub G.H., Van Loan C.F. Matrix Computations 1996, Johns Hopkins University Press, Baltimore. third ed.
37. Hairer E., P.N.S., Wanner G. Solving Ordinary Differential Equations (1): Nonstiff Problems 1993, Springer, Berlin. second ed.
38. Hartmann M., Kessler W. Pharmacokinetics and endogenous production of isoprene in humans. Naunyn-Schmiedberg's Arch. Pharmacol. 1990, 341(Suppl.):R13.
39. Hengl S., Kreutz C., Timmer J., Maiwald T. Data-based identifiability analysis of non-linear dynamical models. Bioinformatics 2007, 23:2612-2618.
40. Huet S., Bouvier A., Poursat M.-A., Jolivet E. Statistical Tools for Nonlinear Regression 2003, Springer, New York.
41. Hughes J.M.B., Morell N.W. Pulmonary Circulation. From Basic Mechanisms to Clinical Practice 2001, Imperial College Press, London.
42. Jacquez J.A., Perry T. Parameter estimation: local identifiability of parameters. Am. J. Physiol. 1990, 258:E727-E736.
43. Johnson A.T. Biomechanics and Exercise Physiology: Quantitative Modeling 2007, CRC Press, Boca Raton. second ed.
44. Karl T., Prazeller P., Mayr D., Jordan A., Rieder J., Fall R., Lindinger W. Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. J. Appl. Physiol. 2001, 91:762-770.
45. Kharitonov S.A., Barnes P.J. Biomarkers of some pulmonary diseases in exhaled breath. Biomarkers 2002, 7:1-32.
46. King, J., Kupferthaler, A., Unterkofler, K., Koc, H., Teschl, S., Teschl, G., Miekisch, W., Schubert, J., Hinterhuber, H., Amann, A., 2009. Isoprene and acetone concentration profiles during exercise on an ergometer. J. Breath Res. 3, 027006 (16pp.). URL: http://arxiv.org/abs/0907.2943.
47. King J., Mochalski P., Kupferthaler A., Unterkofler K., Koc H., Filipiak W., Teschl S., Hinterhuber H., Amann A. Dynamic profiles of volatile organic compounds in exhaled breath as determined by a coupled PTR-MS/GC-MS study. Physiol. Meas. 2010, 31:1169-1184. URL: 〈https://homepages.fhv.at/ku/karl/pdfs/PhysMeas2010.pdf〉.
48. King, J., Unterkofler, K., Teschl, G., Teschl, S., Koc, H., Hinterhuber, H., Amann, A., 2010b. A mathematical model for breath gas analysis of volatile organic compounds with special emphasis on acetone. Preprint, Breath Research Institute, Austrian Academy of Sciences. URL: http://arxiv.org/abs/1003.4475.
49. Kinoyama M., Nitta H., Watanabe A., Ueda H. Acetone and isoprene concentrations in exhaled breath in healthy subjects. J. Health Sci. 2008, 54:471-477.
50. Kuhn E., Lavielle M. Maximum likelihood estimation in nonlinear mixed effects models. Comput. Stat. Data Anal. 2005, 49:1020-1038.
51. Kumagai S., Matsunaga I. A lung model describing uptake of organic solvents and roles of mucosal blood flow and metabolism in the bronchioles. Inhal. Toxicol. 2000, 12:491-510.
52. Kushch I., Arendacka B., Stolc S., Mochalski P., Filipiak W., Schwarz K., Schwentner L., Schmid A., Dzien A., Lechleitner M., Witkovsky V., Miekisch W., Schubert J., Unterkofler K., Amann A. Breath isoprene-aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study. Clin. Chem. Lab. Med. 2008, 46:1011-1018.
53. Leung H.W. Development and utilization of physiologically based pharmacokinetic models for toxicological applications. J. Toxicol. Environ. Health 1991, 32:247-267.
54. Liang P.J., Pandit J.J., Robbins P.A. Statistical properties of breath-to-breath variations in ventilation at constant PET,CO2 and PET,O2 in humans. J. Appl. Physiol. 1996, 81:2274-2286.
55. Ligor T., Ligor M., Amann A., Ager C., Bachler M., Dzien A., Buszewski B. The analysis of healthy volunteers' exhaled breath by the use of solid-phase microextraction and GC-MS. J. Breath Res. 2008, 2:046006.
56. Lindinger W., Hansel A., Jordan A. On-line monitoring of volatile organic compounds at pptv levels by means of proton-transfer-reaction mass spectrometry (PTR-MS)-medical applications, food control and environmental research. Int. J. Mass Spectrom. 1998, 173:191-241.
57. Lindinger W., Hansel A., Jordan A. Proton-transfer-reaction mass spectrometry (PTR-MS): on-line monitoring of volatile organic compounds at pptv levels. Chem. Soc. Rev. 1998, 27:347-354.
58. Lirk P., Bodrogi F., Raifer H., Greiner K., Ulmer H., Rieder J. Elective haemodialysis increases exhaled isoprene. Nephrol. Dial. Transplant. 2003, 18:937-941.
59. Ljung G.M., Box G.E.P. On a measure of lack of fit in time series models. Biometrika 1978, 65:297-303.
60. Lumb A.B. Nunn's Applied Respiratory Physiology 2005, Butterworth-Heinemann, Oxford. sixth ed.
61. McGrath L.T., Patrick R., Silke B. Breath isoprene in patients with heart failure. Eur. J. Heart Fail. 2001, 3:423-427.
62. Melnick R.L., Kohn M.C. Dose-response analyses of experimental cancer data. Drug Metab. Rev. 2000, 32:193-209.
63. Melnick R.L., Sills R.C., Roycroft J.H., Chou B.J., Ragan H.A., Miller R.A. Isoprene, an endogenous hydrocarbon and industrial chemical induces, multiple organ neoplasia in rodents after 26 weeks of inhalation exposure. Cancer Res. 1994, 54:5333-5339.
64. Miekisch W., Schubert J.K. From highly sophisticated analytical techniques to life-saving diagnostics: technical developments in breath analysis. Trends Anal. Chem. 2006, 25:665-673.
65. Miekisch W., Schubert J.K., Noeldge-Schomburg G.F.E. Diagnostic potential of breath analysis-focus on volatile organic compounds. Clin. Chim. Acta 2004, 347:25-39.
66. Miekisch W., Schubert J.K., Vagts D.A., Geiger K. Analysis of volatile disease markers in blood. Clin. Chem. 2001, 47:1053-1060.
67. Mohrman D.E., Heller L.J. Cardiovascluar Physiology 2006, Lange Medical Books, McGraw-Hill, New York. sixth ed.
68. Monte M.D., Citti L., Gervasi P.G. Isoprene metabolism by liver microsomal mono-oxygenases. Xenobiotica 1985, 15:591-597.
69. Mörk A.K., Johanson G. A human physiological model describing acetone kinetics in blood and breath during various levels of physical exercise. Toxicol. Lett. 2006, 164:6-15.
70. Mörk A.-K., Jonsson F., Johanson G. Bayesian population analysis of a washin-washout physiologically based pharmacokinetic model for acetone. Toxicol. Appl. Pharmacol. 2009, 240:423-432.
71. Nelson N., Lagesson V., Nosratabadi A.R., Ludvigsson J., Tagesson C. Exhaled isoprene and acetone in newborn infants and in children with diabetes mellitus. Pediatr. Res. 1998, 44:363-367.
72. NTP, 1999. Toxicology and carcinogenesis studies of isoprene (CAS No. 78-79-5) in F344/N rats (inhalation studies). Technical Report NTP-TR-486, NIH Publication No. 97-3976. Technical Report, National Toxicology Program, Research Triangle Park, NC.
73. Ottesen J.T., Olufsen M.S., Larsen J.K. Applied Mathematical Models in Human Physiology 2004, SIAM, Philadelphia.
74. Pabst F., Miekisch W., Fuchs P., Kischkel S., Schubert J.K. Monitoring of oxidative and metabolic stress during cardiac surgery by means of breath biomarkers: an observational study. J. Cardiothorac. Surg. 2007, 2:37.
75. Peifer M., Timmer J. Parameter estimation in ordinary differential equations for biochemical processes using the method of multiple shooting. IET Syst. Biol. 2007, 1:78-88.
76. Pleil J.D. Role of exhaled breath biomarkers in environmental health science. J. Toxicol. Environ. Health B Crit. Rev. 2008, 11:613-629.
77. Pleil J.D., Kim D., Prah J.D., Ashley D.L., Rappaport S.M. The unique value of breath biomarkers for estimating pharmacokinetic rate constants and body burden from environmental exposures. Breath Analysis for Clinical Diagnosis and Therapeutic Monitoring 2005, 347-359. World Scientific, Singapore. A. Amann, D. Smith (Eds.).
78. Reddy, M.B., Yang, R.S.H., Clewell III, H.J., Andersen, M.E., 2005. Physiologically Based Pharmacokinetic Modeling: Science and Applications. Wiley, Hoboken.
79. Rieder J., Lirk P., Ebenbichler C., Gruber G., Prazeller P., Lindinger W., Amann A. Analysis of volatile organic compounds: possible applications in metabolic disorders and cancer screening. Wien. Klin. Wochenschr. 2001, 113:181-185.
80. Rodriguez-Fernandez M., Egea J.A., Banga J.R. Novel metaheuristic for parameter estimation in nonlinear dynamic biological systems. BMC Bioinformatics 2006, 7:483.
81. Salerno-Kennedy R., Cashman K.D. Potential applications of breath isoprene as a biomarker in modern medicine: a concise overview. Wien. Klin. Wochenschr. 2005, 117:180-186.
82. Schwarz K., Filipiak W., Amann A. Determining concentration patterns of volatile compounds in exhaled breath by PTR-MS. J. Breath Res. 2009, 3:027002. (15pp.).
83. Seber G.A.F., Wild C.J. Nonlinear Regression 2003, Wiley, Hoboken.
84. Shao J., Tu D. The Jackknife and Bootstrap 1995, Springer, New York.
85. Silver G.M., Fall R. Characterization of aspen isoprene synthase, an enzyme responsible for leaf isoprene emission to the atmosphere. J. Biol. Chem. 1995, 270:13010-13016.
86. Smith D., Spanel P., Davies S. Trace gases in breath of healthy volunteers when fasting and after a protein-calorie meal: a preliminary study. J. Appl. Physiol. 1999, 87:1584-1588.
87. Smith D., Spanel P., Enderby B., Lenney W., Turner C., Davies S.J. Isoprene levels in the exhaled breath of 200 healthy pupils within the age range 7-18 years studied using SIFT-MS. J. Breath Res. 2010, 4:017101.
88. Stone B.G., Besse T.J., Duane W.C., Evans C.D., DeMaster E.G. Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men. Lipids 1993, 28:705-708.
89. Sullivan M.J., Knight J.D., Higginbotham M.B., Cobb F.R. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation 1989, 80:769-781.
90. Taucher J., Hansel A., Jordan A., Fall R., Futrell J.H., Lindinger W. Detection of isoprene in expired air from human subjects using proton-transfer-reaction mass spectrometry. Rapid Commun. Mass Spectrom. 1997, 11:1230-1234.
91. Tothill P., Stewart A.D. Estimation of thigh muscle and adipose tissue volume using magnetic resonance imaging and anthropometry. J. Sports Sci. 2002, 20:563-576.
92. Turner C., Spanel P., Smith D. A longitudinal study of breath isoprene in healthy volunteers using selected ion flow tube mass spectrometry (SIFT-MS). Physiol. Meas. 2006, 27:13-22.
93. Wagner P. Ventilation-perfusion matching during exercise. Chest 1992, 101:192S-198S.
94. Wagner P.D. The multiple inert gas elimination technique (MIGET). Intensive Care Med. 2008, 34:994-1001.
95. Watson W.P., Cottrell L., Zhang D., Golding B.T. Metabolism and molecular toxicology of isoprene. Chem. Biol. Interact. 2001, 135-136:223-238.
96. Weitzberg E., Lundberg J.O.N. Humming greatly increases nasal nitric oxide. Am. J. Respir. Crit. Care Med. 2002, 166:144-145.
97. West J.B. Respiratory Physiology the Essentials 2005, Lippincott Williams & Wilkins, Baltimore. seventh ed.